Atomwise

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions. The Company's tools can tell the difference between great drug candidates and toxic ones, and discover new uses for old medicines.

Company Growth (employees)
Type
Private
HQ
San Francisco, US
Founded
2012
Size (employees)
11 (est)
Atomwise was founded in 2012 and is headquartered in San Francisco, US

Atomwise Office Locations

Atomwise has an office in San Francisco

Atomwise Financials and Metrics

Summary Metrics

Founding Date

2012

Total Funding

$6.6 m

Latest funding size

$6 m

Time since last funding

over 2 years

Investors

Atomwise's latest funding round in June 2015 was reported to be $6 m. In total, Atomwise has raised $6.6 m

Traffic Overview of Atomwise

Atomwise Online and Social Media Presence

Atomwise Company Life and Culture

You may also be interested in